Icono del sitio Dra. Carolina Frederico (HG)

Can We Really Associate Alpha Power with Mortality?

Recently, I read an interesting article:

Mather et al. «Intraoperative Frontal Electroencephalogram Alpha Power Is Associated with Postoperative Mortality and Other Adverse Outcomes.» Anesthesiology 2025; 142:500–10.

The study suggests that lower intraoperative alpha power in the EEG is independently associated with increased postoperative mortality. While this is an intriguing hypothesis, I believe we must be cautious with these conclusions.


Critical Points to Consider

1. Lack of Information on Consciousness State Titration

The study reports anaesthetic doses, including

Without data on titration strategies, we cannot determine whether lower alpha power reflects patient frailty or simply excessive anesthesia administration.


2. Retrospective Study Design and Selection Bias

A prospective study is needed to validate these findings before drawing clinical conclusions.


3. Failure to Differentiate Between Patient Frailty and Over-Titration of Anesthesia

Low intraoperative alpha power could result from:
1. Pre-existing neurological frailty ? reduced cortical connectivity and baseline EEG activity.
2. Inadequate titration of consciousness state ? deeper hypnotic states leading to EEG suppression.
3. Cerebral hypoperfusion ? low MAP causing decreased cortical activity.

The study does not provide enough data to distinguish between these scenarios.


4 Unusual Anesthetic Practice: Predominance of Volatile Agents & Nitrous Oxide

One striking aspect of this study is the low use of total intravenous anesthesia (TIVA) and the high prevalence of volatile agents and nitrous oxide:

The study did not investigate whether the choice of anaesthesia influenced the EEG findings, and it could be questioned whether the findings would be the same in a cohort with predominantly intravenous anaesthesia.


5 No Comparison with Established Risk Prediction Models


Final Thoughts

At this stage, it is premature to consider intraoperative alpha power as an independent biomarker for mortality.
More rigorous, prospective studies are needed, incorporating Raw EEG/DSA, MAP, burst suppression analysis, and direct comparisons with existing risk models.

Additionally, the high use of volatile agents and nitrous oxide raises the question of whether these findings would hold true in a TIVA-based anesthesia protocol.

What are your thoughts on this? Have you encountered similar discussions in your practice?

Salir de la versión móvil